Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Март 19, 2025
Anti-programmed
death
1
(αPD1)
immune
checkpoint
blockade
is
used
in
combination
for
cancer
treatment
but
associated
with
cardiovascular
toxicity.
Leflunomide
(Lef)
can
suppress
the
growth
of
several
tumor
and
mitigate
cardiac
remodeling
mice.
However,
role
Lef
αPD1-induced
cardiotoxicity
remains
unclear.
Here,
we
report
that
inhibits
αPD1-related
without
compromising
efficacy
αPD1-mediated
immunotherapy.
changes
community
structure
gut
microbiota
αPD1-treated
melanoma-bearing
Moreover,
mice
receiving
transplants
from
Lef+αPD1-treated
have
better
function
compared
to
Mechanistically,
analyze
metabolomics
identify
indole-3-propionic
acid
(IPA),
which
protects
dysfunction
IPA
directly
bind
aryl
hydrocarbon
receptor
promote
phosphoinositide
3-kinase
expression,
thus
curtailing
cardiomyocyte
response
injury.
Our
findings
reveal
mitigates
toxicity
through
modulation
microbiota-IPA-heart
axis.
The
authors
show
leflunomide
microbiota-indole-3-propionic
acid-heart
Angiogenesis,
Год журнала:
2024,
Номер
27(4), С. 623 - 639
Опубликована: Июль 26, 2024
Abstract
As
a
vital
component
of
blood
vessels,
endothelial
cells
play
key
role
in
maintaining
overall
physiological
function
by
residing
between
circulating
and
semi-solid
tissue.
Various
stress
stimuli
can
induce
injury,
leading
to
the
onset
corresponding
diseases
body.
In
recent
years,
importance
mitochondria
vascular
injury
has
become
increasingly
apparent.
Mitochondria,
as
primary
site
cellular
aerobic
respiration
organelle
for
“energy
information
transfer,”
detect
cell
damage
integrating
receiving
various
external
signals.
The
generation
reactive
oxygen
species
(ROS)
mitochondrial
dysfunction
often
determine
evolution
towards
necrosis
or
apoptosis.
Therefore,
are
closely
associated
with
function,
helping
progression
clinical
diseases.
This
article
comprehensively
reviews
interconnection
pathogenesis
mitochondrial-induced
cardiovascular
diseases,
renal
pulmonary-related
cerebrovascular
microvascular
diabetes.
Corresponding
therapeutic
approaches
also
provided.
Additionally,
strategies
using
drugs
treat
injury-based
discussed,
aiming
offer
new
insights
treatment
options
diagnosis
related
injuries.
Circulation Research,
Год журнала:
2025,
Номер
136(5), С. 524 - 550
Опубликована: Фев. 27, 2025
Cardiovascular
diseases
(CVDs)
are
experiencing
a
rapid
surge
and
widely
recognized
as
the
leading
cause
of
mortality
in
current
aging
society.
Given
multifactorial
etiology
CVDs,
understanding
intricate
molecular
cellular
mechanisms
is
imperative.
Over
past
2
decades,
many
scientists
have
focused
on
Sirtuins,
family
nicotinamide
adenine
dinucleotide–dependent
deacylases.
Sirtuins
highly
conserved
across
species,
from
yeasts
to
primates,
play
crucial
role
linking
diseases.
participate
nearly
all
key
physiological
pathological
processes,
ranging
embryogenic
development
stress
response
aging.
Abnormal
expression
activity
exist
aging-related
diseases,
while
their
activation
has
shown
efficacy
mitigating
these
(eg,
CVDs).
In
terms
research,
this
field
maintained
fast,
sustained
growth
recent
years,
fundamental
studies
clinical
trials.
review,
we
present
comprehensive,
up-to-date
discussion
biological
functions
roles
regulating
cardiovascular
biology
CVDs.
Furthermore,
highlight
latest
advancements
utilizing
Sirtuin-activating
compounds
dinucleotide
boosters
potential
pharmacological
targets
for
preventing
treating
The
unresolved
issues
field—from
chemicobiological
regulation
Sirtuin-targeted
CVD
investigations—are
also
discussed.
This
timely
review
could
be
critical
updated
knowledge
Sirtuin
CVDs
facilitating
accessibility
Sirtuin-targeting
interventions.
Biomimetics,
Год журнала:
2025,
Номер
10(2), С. 73 - 73
Опубликована: Янв. 24, 2025
The
gut
microbiota
is
a
complex
and
dynamic
ecosystem
that
plays
fundamental
role
in
human
health
by
regulating
immunity,
metabolism,
the
gut–brain
axis.
Beyond
its
critical
physiological
functions,
it
has
emerged
as
rich
source
of
inspiration
for
biomimetic
innovations
healthcare
biotechnology.
This
review
explores
transformative
potential
microbiota-based
biomimetics,
focusing
on
key
biological
mechanisms
such
resilience,
self-regulation,
quorum
sensing.
These
have
inspired
development
innovative
applications,
including
personalized
probiotics,
synbiotics,
artificial
microbiomes,
bioinspired
biosensors,
bioremediation
systems.
Such
technologies
aim
to
emulate
optimize
intricate
functions
microbial
ecosystems,
addressing
challenges
environmental
sustainability.
integration
advanced
technologies,
intelligence,
bioengineering,
multi-omics
approaches,
further
accelerated
biomimetics.
tools
enable
precision
therapies
tailored
individual
profiles,
enhance
efficacy
diagnostic
systems,
facilitate
design
environmentally
sustainable
solutions,
waste-to-energy
systems
platforms.
Emerging
areas
innovation,
gut-on-chip
models
synthetic
biology,
offer
unprecedented
opportunities
studying
applying
principles
controlled
environments.
Despite
these
advancements,
remain.
replication
complexity
environments,
ethical
concerns
regarding
genetically
engineered
microorganisms,
equitable
access
are
hurdles
must
be
addressed.
underscores
importance
interdisciplinary
collaboration
public
awareness
overcoming
barriers
ensuring
responsible
solutions.
By
leveraging
biomimetics
represents
promising
frontier
approach
revolutionize
therapeutic
strategies,
redefine
tools,
address
global
challenges,
paving
way
more
personalized,
efficient,
future
medicine
Abstract
The
prevalence
of
many
chronic
noncommunicable
diseases
has
been
steadily
rising
over
the
past
six
decades.
During
this
time,
350,000
new
chemical
substances
have
introduced
to
lives
humans.
In
recent
years,
epithelial
barrier
theory
came
light
explaining
growing
and
exacerbations
these
worldwide.
It
attributes
their
onset
a
functionally
impaired
triggered
by
toxicity
exposed
substances,
associated
with
microbial
dysbiosis,
immune
system
activation,
inflammation.
Diseases
encompassed
share
common
features
such
as
an
increased
after
1960s
or
2000s
that
cannot
(solely)
be
accounted
for
emergence
improved
diagnostic
methods.
Other
traits
include
defects,
dysbiosis
loss
commensals
colonization
opportunistic
pathogens,
circulating
inflammatory
cells
cytokines.
addition,
practically
unrelated
fulfill
criteria
started
emerge
multimorbidities
during
last
Here,
we
provide
comprehensive
overview
discuss
evidence
similarities
epidemiology,
genetic
susceptibility,
dysfunction,
tissue
Nutrients,
Год журнала:
2024,
Номер
16(17), С. 2838 - 2838
Опубликована: Авг. 24, 2024
The
gut
microbiota
constitutes
a
complex
ecosystem,
comprising
trillions
of
microbes
that
have
co-evolved
with
their
host
over
hundreds
millions
years.
Over
the
past
decade,
growing
body
knowledge
has
underscored
intricate
connections
among
diet,
microbiota,
and
human
health.
Bioactive
polysaccharides
(BPs)
from
natural
sources
like
medicinal
plants,
seaweeds,
fungi
diverse
biological
functions
including
antioxidant,
immunoregulatory,
metabolic
activities.
Their
effects
are
closely
tied
to
which
metabolizes
BPs
into
health-influencing
compounds.
Understanding
how
interact
is
critical
for
harnessing
potential
health
benefits.
This
review
provides
an
overview
focusing
on
its
role
in
diseases
obesity,
type
II
diabetes
mellitus,
non-alcoholic
fatty
liver
disease,
cardiovascular
diseases.
It
explores
basic
characteristics
several
impact
microbiota.
Given
significance
health,
we
summarize
these
BPs,
particularly
terms
immunoregulatory
activities,
blood
sugar,
hypolipidemic
effect,
thus
providing
valuable
reference
understanding
benefits
treating
These
properties
make
promising
agents
preventing
comprehensive
mechanisms
by
exert
through
opens
new
avenues
developing
targeted
therapies
improve
Abstract
Recent
advances
in
understanding
the
modulatory
functions
of
gut
and
microbiota
on
human
diseases
facilitated
our
focused
attention
contribution
to
pathophysiological
alterations
many
extraintestinal
organs,
including
liver,
heart,
brain,
lungs,
kidneys,
bone,
skin,
reproductive,
endocrine
systems.
In
this
review,
we
applied
“gut–X
axis”
concept
describe
linkages
between
other
organs
discussed
latest
findings
related
axis,”
underlying
mechanisms
potential
clinical
intervention
strategies.
Journal of Inflammation Research,
Год журнала:
2024,
Номер
Volume 17, С. 5293 - 5309
Опубликована: Авг. 1, 2024
Patients
with
sepsis
frequently
develop
septic
cardiomyopathy,
which
is
known
to
be
closely
related
excessive
inflammatory
responses.
Indole-3-propionic
acid
(IPA)
a
tryptophan
metabolite
anti-inflammatory
properties
that
have
been
demonstrated
in
various
studies.
In
this
study,
we
investigated
the
underlying
mechanisms
and
therapeutic
role
of
IPA
cardiomyopathy.